MedPath

TENS Device Shows Promise in Alleviating Long COVID Symptoms

a year ago2 min read

Key Insights

  • A new study suggests that Transcutaneous Electrical Nerve Stimulation (TENS) may reduce pain and fatigue associated with long COVID.

  • Participants using the TENS device reported a 26% reduction in pain and an 8% improvement in walking ability compared to the placebo group.

  • The TENS device was found to be easy to use, promoting high compliance among participants in the study.

A Transcutaneous Electrical Nerve Stimulation (TENS) device, commonly used for arthritis and back pain, may offer relief for long COVID symptoms, particularly fatigue and pain, according to a recent study.

Study Details

The study, published in Nature Scientific Reports, involved 25 participants diagnosed with chronic musculoskeletal pain, fatigue, and gait difficulties related to long COVID. Participants were randomly assigned to use either a high-dose TENS device or a placebo device for three to five hours daily over one month. The active TENS device delivers low-wattage electrical currents to stimulate nerves.

Key Findings

Results indicated that participants using the real TENS device experienced a 26% reduction in pain compared to the placebo group. Additionally, an 8% improvement in walking ability was observed. Overall, 71% of participants using the TENS device reported a noticeable health benefit, compared to 61.4% in the placebo group.
Bijan Najafi, research director at UCLA Health's Center for Advanced Surgical & Interventional Technology and co-lead author, noted the device's ease of use and potential for integration into daily activities.

TENS Device and Long COVID

Long COVID is estimated to affect 1 in 13 U.S. adults, with symptoms including fatigue, pain, and muscle weakness. The TENS device offers a non-invasive method to manage these symptoms through nerve stimulation.

Future Research

While the study showed promising results, Najafi emphasized the need for further research to validate these findings, citing the limited sample size. The study was primarily funded by the National Science Foundation, with Neurometrix Inc. providing the Quell TENS devices.

Potential Applications

Researchers suggest that TENS may have broader applications for managing similar symptoms in other conditions, such as respiratory diseases, post-ICU weakness, fibromyalgia, and chemotherapy-related side effects. Further studies are needed to explore these potential uses.
Subscribe Icon

Stay Updated with Our Daily Newsletter

Get the latest pharmaceutical insights, research highlights, and industry updates delivered to your inbox every day.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.